Annual report pursuant to Section 13 and 15(d)

3. Summary of Significant Accounting Policies (Tables)

v3.19.2
3. Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Disaggregated Revenue by Source
   

Year Ended

March 31,

  
    2019     2018  
Product            
Human Skin Care   $ 15,912,000     $ 14,277,000  
Animal Skin Care     1,969,000       1,386,000  
      17,881,000       15,663,000  
Service     1,089,000       995,000  
Total   $ 18,970,000     $ 16,658,000  
Property and equipment estimated useful life
    Years  
Office equipment     3  
Manufacturing, lab and other equipment     5  
Furniture and fixtures     7  
Schedule of antidilutive shares
    March 31,  
    2019     2018  
Common stock to be issued upon vesting of restricted stock units     4,000       4,000  
Common stock to be issued upon exercise of options     165,000       155,000  
Common stock to be issued upon exercise of warrants     446,000       153,000  
Common stock to be issued upon conversion of Series C     17,000       –  
Common stock to be issued upon exercise of common stock units (1)     46,000       –  
      678,000       312,000